SecBot SecBot
8-K ·Filed Apr 3, 2026

GRTX

Galera Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed6mo ago SEC0001193125-26-141187
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Traders should monitor for any stockholder proposals or activist activity ahead of the April 13 deadline, though this filing itself is procedural and unlikely to move the stock. No financial or operational updates were provided.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
GRTX ▲ +114.63% at T+60d
NEUTRAL call +114.63% · α vs SPY +101.17% · entry $0.0410 → $0.0880
Entry = T+0 close
Apr 3, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.06%
$0.0410
settled 7mo ago
T+5d
+2.44%
call +2.44% · α -1.70%
$0.0420
settled 7mo ago
T+20d
+129.27%
call +129.27% · α +120.29%
$0.0940
settled 6mo ago
T+60d
+114.63%
call +114.63% · α +101.17%
$0.0880
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Galera Therapeutics has scheduled its Combined 2025 and 2026 Annual Meeting of Stockholders for May 8, 2026, and set April 13, 2026, as the deadline for stockholders to submit proposals or director nominations. This filing provides procedural notice for governance-related submissions ahead of the annual meeting.

Key Facts

  • Annual Meeting of Stockholders scheduled for May 8, 2026
  • Deadline for stockholder proposals and director nominations is April 13, 2026
  • Meeting is a combined 2025 and 2026 annual meeting
  • Proposals must be received by or before April 13, 2026 to be considered timely under company bylaws and SEC rules

Financial Impact

No direct financial impact disclosed

Risk Factors

  • Potential for activist shareholder activity if proposals are filed near the deadline
  • Governance-related news could emerge in coming weeks as proxy season approaches

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-141187
Document: 0001193125-26-141187-index-headers.html0001193125-26-141187
Document: 0001193125-26-141187-index.html0001193125-26-141187
Document: 0001193125-26-141187.txt0001193125-26-141187
13 reports for GRTX
Performance horizon
50% Hit rate @ T+20 2 of 4 directional calls Went positive at some point 3 of 5 best @ T+20▲ +15.15%May 19, 2026
Filters
Rows
Reports for GRTX — sortable, filterable
TypeNow
Aug 10, 2026
11w ago
EFFECT
BEARISH ★ 6/10
—awaiting T+20——
Aug 4, 2026
11w ago
15-12G
NEUTRAL ★ 4/10
—awaiting T+20——
Aug 3, 2026
11w ago
8-K
BEARISH ★ 8/10
—awaiting T+20——
Jul 13, 2026
14w ago
8-K
NEUTRAL ★ 4/10
$16.39awaiting T+20——
Jul 7, 2026
15w ago
8-K
BEARISH ★ 6/10
$17.80awaiting T+20——
May 21, 2026
22w ago
425
BULLISH ★ 7/10
$0.1000 $0.0910▼ −9.00%▼ −7.58%—
May 19, 2026
22w ago
8-K
BEARISH ★ 8/10
$0.1010 $0.0857▲ +15.15%▲ +15.89%—
Apr 22, 2026
26w ago
425
BULLISH ★ 7/10
$20.00 $20.20▲ +1.00%▼ −3.22%—
Apr 22, 2026
26w ago
425
NEUTRAL ★ 5/10
$20.00 $20.20▲ +1.00%▼ −3.22%—
Apr 14, 2026
27w ago
Press Release
BEARISH ★ 7/10
$0.0790 $0.1000▼ −26.58%▼ −20.29%—
Showing 10 of 13

US Market Status

Market Open — Closes in 4h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 3, 2026